INVO Bioscience acquires Wisconsin Fertility Institute to expand INVOcell solution footprint
Healthcare fertility giant, INVO Bioscience, Inc. (Nasdaq: INVO), known for its revolutionary INVOcell medical device and accompanying intravaginal culture (IVC) procedure, has confirmed the acquisition of the esteemed Wisconsin Fertility Institute. This strategic acquisition aligns with INVO’s ambitious vision, boosting its operational scale and cash flow while complementing the Company’s progressive INVO Center strategy. The […]